About
Synthetic Peptides
Areas of Focus
Categories
Gene Therapy, RNA & Peptide Therapy
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
13
As Collaborator
0
Total Enrollment
5,361
By Phase
PHASE3: 9PHASE2: 2PHASE1: 1
By Status
COMPLETED: 8ACTIVE_NOT_RECRUITING: 2RECRUITING: 1NOT_YET_RECRUITING: 1ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07127978Lead Sponsor
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
N/ARecruiting
300 participants
Started: Oct 31, 2025 · Completed: Jul 30, 2030
NCT07102511Lead Sponsor
Randomized, Placebo-Controlled, Double-Blind, Phase 3b Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH
PHASE3Not yet recruiting
150 participants
Started: Sep 1, 2025 · Completed: Jun 30, 2027
NCT05004675Lead Sponsor
Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients
PHASE3Completed
166 participants
Started: Jun 20, 2022 · Completed: Oct 15, 2024
NCT05234775Lead Sponsor
Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product
PHASE3Completed
22 participants
Started: Jan 28, 2022 · Completed: Jul 11, 2022
NCT04790513Lead Sponsor
Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients
PHASE3Completed
204 participants
Started: Apr 22, 2021 · Completed: Dec 31, 2022
Locations (1)
Headquarters
Glasgow, UK
Map
Loading map...